← Back to Clinical Trials
Recruiting NCT05718063

NCT05718063 MAP for Coaches: Translating Sports Injury Prevention Knowledge to Youth Sport Coaches

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05718063
Status Recruiting
Phase —
Sponsor St. Louis University
Condition Knowledge, Attitudes, Practice
Study Type INTERVENTIONAL
Enrollment 200 participants
Start Date 2023-08-08
Primary Completion 2026-12

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
MAP for Coaches - Complete CourseMap for Coaches - Overview

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 200 participants in total. It began in 2023-08-08 with a primary completion date of 2026-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to test the effectiveness of the MAP for Coaches, a web-based Musculoskeletal Athletic injury Prevention training course, in youth sport coaches. The main question it aims to answer are: * Is the MAP for Coaches effective in increasing coaches' sport-specific knowledge of musculoskeletal injuries (types, incidence, risk factors, mechanisms, and best prevention practices, with focus on neuromuscular training warm-up exercise programs)? * Is the MAP for Coaches effective in increasing coaches' motivation (self-efficacy and intention) to use sport-specific neuromuscular training warm-up exercise programs? The additional questions it aims to answer are: * Are the effects of the MAP for Coaches sustained in the short- and long-term? * Is the MAP for Coaches effective in promoting the use of sport-specific neuromuscular training warm-up exercise programs in youth sport coaches? Regardless of group, participants will receive the MAP for Coaches eLearning training course; however, the participants allocated to the control group will have their post-test survey completed right after they review the sport-specific 2-page injury prevention e-book containing an overview of the MAP for Coaches training course, including an infographic summary (Summarized MAP for Coaches eLearning Training Course). The intervention group will complete the post-test survey after the full training including both the course summary and the detailed course modules (the full training). The investigators will compare the two groups to see if an exposure to the (Full) MAP for Coaches eLearning Training Course improves study outcomes compared with the control group.

Eligibility Criteria

Inclusion Criteria: * Active and ongoing engagement in team youth sport coaching * Member of a youth sport organization in the United States * Must be a team sport coach for one of the following: soccer, basketball, football or volleyball Exclusion Criteria: * Additional engagement in adult coaching * No email address contact

Contact & Investigator

Central Contact

Olu Owoeye, PhD

✉ olu.owoeye@health.slu.edu

📞 3149778546

Principal Investigator

Olu Owoeye, PhD

PRINCIPAL INVESTIGATOR

St. Louis University

Frequently Asked Questions

Who can join the NCT05718063 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Knowledge, Attitudes, Practice. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05718063 currently recruiting?

Yes, NCT05718063 is actively recruiting participants. Contact the research team at olu.owoeye@health.slu.edu for enrollment information.

Where is the NCT05718063 trial being conducted?

This trial is being conducted at St Louis, United States.

Who is sponsoring the NCT05718063 clinical trial?

NCT05718063 is sponsored by St. Louis University. The principal investigator is Olu Owoeye, PhD at St. Louis University. The trial plans to enroll 200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology